Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice.

The aim of the present study was to investigate the efficacy of treatment with a combination of fluconazole and human recombinant interleukin-1 alpha (IL-1 alpha) in normal or neutropenic mice with systemic Candida albicans infection. Six hours after intravenous injection of 5 x 10(4) CFU of C. albi...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Kullberg, B J, van 't Wout, J W, Poell, R J, van Furth, R
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1992
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190322/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1416821/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.6.1225
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!